Company news
Sunshine Biopharma Inc. news in 2020
Sunshine Biopharma Inc.'s news releases, calls and decks from 2020, newest first.
Sunshine Biopharma’s Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK
December 21, 2020
Sunshine Biopharma Orders a New Batch of Adva-27a for Testing on TOPII Amplified Cancers
December 7, 2020
Sunshine Biopharma Pays Off Convertible Notes in Cash Preventing New Shares From Hitting the Market
December 2, 2020
Sunshine Biopharma Receives Third Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
November 30, 2020
Sunshine Biopharma Believes That an Effective Coronavirus Treatment Continues to Be Necessary
November 23, 2020
Sunshine Biopharma Signs an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound
November 17, 2020
Sunshine Biopharma Signs an Agreement for Distribution of Essential-9(TM) in Asia and the Far East
November 9, 2020
Sunshine Biopharma Receives Second Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
October 25, 2020
Sunshine Biopharma Identifies a Lead Anti-Coronavirus Compound
October 6, 2020
Sunshine Biopharma Secures $2,000,000 + Financing for Coronavirus Treatment
September 14, 2020
Sunshine Biopharma Completes the Synthesis of Four Potential Inhibitors of Coronavirus Protease
August 24, 2020
Sunshine Biopharma Files A Patent Application For A New Coronavirus COVID-19 Treatment
June 2, 2020